Stage I Breast Cancer and a Separate Mixed Primary Liver Cancer in a 62-Year-Old Woman
This breast cancer diagnosis at a glance
- Stage at diagnosis
- Stage I
- Subtype
- Invasive Ductal Carcinoma
- Biomarkers
- HER2/CerbB-2 positive
- Sex
- Female
- Treatment
- chemotherapy, targeted therapy and surgery
- Outcome
- Responding Well
Treatment course, step by step
- Received 4 cycles of docetaxel, cyclophosphamide, and trastuzumab for the breast cancer.
- Continued trastuzumab for 1 year.
- Underwent left breast resection with sentinel lymph node biopsy in September 2022.
What happened, in summary
A 62-year-old woman presented in June 2022 with a small left breast mass. Biopsy showed high-grade invasive ductal carcinoma. Imaging also found several liver masses, creating concern that the breast cancer might have spread.
Because the liver disease appeared more aggressive, she underwent liver surgery first. Pathology showed that the liver tumors were not breast-cancer metastases but a separate mixed primary liver cancer containing hepatocellular and intrahepatic cholangiocarcinoma components.
Her breast cancer was then treated with 4 cycles of docetaxel, cyclophosphamide, and trastuzumab, with trastuzumab continued for a total of 1 year. In September 2022, she underwent left breast resection with sentinel lymph node biopsy. Postoperative pathology showed Stage I invasive ductal carcinoma with no involved sentinel lymph nodes. The breast tumor did not progress. The separate liver cancer required its own surgical management and follow-up.
Where this story comes from
This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full
How we source and attribute stories Accuracy and limitations
Collections this story belongs to
- Stage 1 Breast Cancer 113 stories
- Chemotherapy for Stage 1 Breast Cancer 51 stories
- HER2 Positive Breast Cancer 136 stories
- Chemotherapy for Breast Cancer 726 stories
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer